Ratings by Wedbush (Martin Fan)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/17/2026 Immunic Inc. IMUX New Coverage Outperform
(N/A)
16.06
(11.84)
-26.28% Details
4/27/2026 Oruka Therapeutics ORKA Maintain Outperform
(N/A)
 
 
  Details
4/24/2026 First Tracks Biotherapeutics TRAX New Coverage Outperform
(N/A)
19.00
(37.98)
99.89% Details
4/20/2026 Nektar Therapeutics NKTR Maintain Neutral
(N/A)
 
 
  Details
4/14/2026 Sana Biotechnology SANA Maintain Outperform
(N/A)
 
 
  Details
3/24/2026 Nektar Therapeutics NKTR New Coverage Neutral
(N/A)
74.34
(70.65)
-4.96% Details
2/9/2026 Zura Bio Ltd. ZURA New Coverage Outperform
(N/A)
6.01
(5.38)
-10.48% Details
11/25/2025 ImageneBio IMA New Coverage Underperform
(N/A)
6.91
(5.01)
-27.5% Details
11/25/2025 Vor Biopharma, Inc. VOR New Coverage Neutral
(N/A)
8.36
(22.34)
167.22% Details
10/27/2025 Fate Therapeutics FATE Upgrade Outperform
(Neutral)
1.65
(2.33)
41.21% Details
9/24/2025 Sana Biotechnology SANA New Coverage Outperform
(N/A)
3.26
(3.09)
-5.21% Details
7/9/2025 Cartesian Therapeutics RNAC New Coverage Outperform
(N/A)
11.30
(8.43)
-25.4% Details
5/28/2025 Aclaris Therapeutis ACRS New Coverage Outperform
(N/A)
1.27
(5.51)
333.86% Details
3/20/2025 Zenas Biopharma ZBIO New Coverage Outperform
(N/A)
8.25
(31.10)
276.97% Details